Ignite Creation Date:
2024-05-06 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03423199
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-22
First Post:
2018-01-09
Brief Title:
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive HER2-negative Advanced Breast Cancer Women - Asian studY
Sponsor:
National Cancer Center Japan
Organization:
National Cancer Center Japan
Organization Data
Organization:
National Cancer Center Japan
Class:
OTHER_GOV
Study ID:
NCCH1607
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Center Japan
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |
| Korean Cancer Study Group | OTHER |